Search Within

Kyuichi Kadota

Formats
  1. Journal Article (46)
  2. Meeting Abstract (39)
Groups
  1. Surgery (78)
  2. Department of Pathology and Laboratory Medicine (76)
  3. Department of Medicine (25)
  4. Sloan Kettering Institute Postdocs (18)
  5. Solid Tumor Oncology Division (17)
  6. GSK Faculty (15)

More Groups

People
  1. Prasad Adusumilli (78)
  2. William Travis (73)
  3. Valerie Rusch (45)
  4. Camelia Sima (42)
  5. Jun - Ichi Nitadori (25)
  6. David Jones (21)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2018 (3)
  4. 2017 (3)
  5. 2016 (6)
  6. 2015 (17)

More Years

Publications
  1. Journal of Thoracic Oncology (22)
  2. Modern Pathology (15)
  3. Laboratory Investigation (11)
  4. American Journal of Surgical Pathology (4)
  5. Clinical Cancer Research (4)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. Nature Research (15)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (5)
  5. American Society of Clinical Oncology (4)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes
    Journal Article

    Chang, J. C.; Offin, M.; Falcon, C.; Brown, D.; Houck-Loomis, B. R.; Meng, F.; Rudneva, V. A.; Won, H. H.; Amir, S.; Montecalvo, J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (≤2 cm) lung adenocarcinoma: An international cohort analysis
    Journal Article

    Bains, S.; Eguchi, T.; Warth, A.; Yeh, Y. C.; Nitadori, J. I.; Woo, K. M.; Chou, T. Y.; Dienemann, H.; Muley, T.; Nakajima, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Impact of tumor spread through air spaces (STAS) in lung neuroendocrine tumors (NETs)
    Meeting Abstract

    Aly, R.; Eguchi, T.; Kadota, K.; Rekhtman, N.; Tan, K. S.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Implications of the eighth edition of the TNM proposal: Invasive versus total tumor size for the T descriptor in pathologic stage I-IIA lung adenocarcinoma
    Journal Article

    Kameda, K.; Eguchi, T.; Lu, S.; Qu, Y.; Tan, K. S.; Kadota, K.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations
    Journal Article

    Rekhtman, N.; Pietanza, C. M.; Sabari, J.; Montecalvo, J.; Wang, H.; Habeeb, O.; Kadota, K.; Adusumilli, P.; Rudin, C. M.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Tumor spread through air spaces (STAS) in lung squamous cell cancer is an independent risk factor: A competing risk analysis
    Meeting Abstract

    Lu, S.; Eguchi, T.; Tan, K. S.; Bains, S.; Kadota, K.; Rekhtman, N.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: Expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Journal Article

    Eguchi, T.; Kadota, K.; Mayor, M.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Spread through Air Spaces (STAS) is an independent predictor of recurrence and lung cancer-specific death in squamous cell carcinoma
    Journal Article

    Lu, S.; Tan, K. S.; Kadota, K.; Eguchi, T.; Bains, S.; Rekhtman, N.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • KRAS mutation is a significant prognostic factor in early-stage lung adenocarcinoma
    Journal Article

    Kadota, K.; Sima, C. S.; Arcila, M. E.; Hedvat, C.; Kris, M. G.; Jones, D. R.; Adusumilli, P. S.; Travis, W. D.
    American Journal of Surgical Pathology (2016)

    Fulltext@MSK | Save
  • Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
    Journal Article

    Eguchi, T.; Kadota, K.; Chaft, J.; Evans, B.; Kidd, J.; Tan, K. S.; Dycoco, J.; Kolquist, K.; Davis, T.; Hamilton, S. A.; more...
    Oncotarget (2016)

    Fulltext@MSK | Save